PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
11/26/11	NT$11.10	-1.77%	5,05,349
10/26/10	NT$11.30	0.00%	1,15,785
09/26/09	NT$11.30	+0.89%	98,783
08/26/08	NT$11.20	-1.75%	1,34,299
07/26/07	NT$11.40	0.00%	1,20,355

End-of-day quote Taiwan S.E.

More quotes

End-of-day quote Taiwan S.E. 11/09/2026			5-day change	1st Jan Change
11.10 ^TWD	-1.77%		-2.63%	-17.78%

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT

Market Cap	220.47Cr 6.97Cr 6.01Cr 5.69Cr 5.15Cr 9.67Cr 665.94Cr 9.72Cr 68Cr 26Cr 338.8Cr 26Cr 26Cr 1.07TCr	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	115.57Cr 3.65Cr 3.15Cr 2.98Cr 2.7Cr 5.07Cr 349.08Cr 5.09Cr 35Cr 14Cr 177.6Cr 14Cr 13Cr 561.19Cr	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.14%	Yield 2024 *	-	Yield 2025	-

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT
11/05	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02/03	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
10/11	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/25/22	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/25/13	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/25/06	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/25/05	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
04/25/04	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/25/06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/25/06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/25/27	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI

09/22/09	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/22/05	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/22/24	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/22/08	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/22/09	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Share Price

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation : PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases : PhytoHealth Corporation

Quotes and Performance

Price Extremes

Managers and Directors : PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

1 day	-1.77%
1 week	-2.63%
Current month	-3.90%
3 months	-9.02%
6 months	-17.47%
Current year	-17.78%

1 week	11	11.45
1 month	10.7	12.5
Current year	10.7	15.25
1 year	10.7	16.65
3 years	10.7	24
5 years	10.7	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	13/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	11/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	30/07/2021

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	10/06/2011
Yue Ju Lai BRD	Director/Board Member	-	16/03/2010
Yi Li Lee CHM	Chairman	55	26/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-1.77%	-2.63%	-31.69%	-44.22%	6.97Cr
REGENERON PHARMACEUTICALS, INC.	-1.48%	-5.59%	+37.54%	-6.24%	7.8TCr
CSL LIMITED	-1.42%	-4.24%	-18.81%	-37.78%	5.74TCr
MODERNA, INC.	+5.38%	-1.09%	+467.03%	+36.08%	5.75TCr
SAMSUNG BIOLOGICS CO.,LTD.	-0.56%	-2.21%	-11.17%	+25.38%	4.88TCr
UCB	+1.93%	-2.37%	-2.00%	+149.45%	4.55TCr
BIOGEN INC.	+0.80%	-1.67%	+45.89%	-16.13%	3.21TCr
INCYTE CORPORATION	-1.47%	-4.17%	+40.97%	+88.59%	2.46TCr
INNOVENT BIOLOGICS, INC.	-0.85%	-8.64%	-3.66%	+144.26%	2.08TCr
SWEDISH ORPHAN BIOVITRUM AB	-0.09%	-3.61%	+63.58%	+97.66%	1.57TCr
Average	+0.05%	-3.75%	+58.77%	+43.70%	3.8TCr
Weighted average by Cap.	+0.38%	-3.71%	+82.69%	+35.88%

	2024	2025
Net sales	15Cr 48.55L 41.83L 39.61L 35.9L 67.36L 46Cr 67.7L 4.7Cr 1.81Cr 24Cr 1.82Cr 1.78Cr 75Cr	13Cr 42.55L 36.66L 34.71L 31.46L 59.03L 41Cr 59.33L 4.12Cr 1.59Cr 21Cr 1.6Cr 1.56Cr 65Cr
Net income	-7.35Cr -23.24L -20.02L -18.96L -17.18L -32.24L -22Cr -32.4L -2.25Cr -86.59L -11Cr -87.28L -85.36L -36Cr	-5.82Cr -18.4L -15.85L -15.01L -13.61L -25.53L -18Cr -25.66L -1.78Cr -68.56L -8.94Cr -69.11L -67.59L -28Cr
Net Debt	-106.19Cr -3.36Cr -2.89Cr -2.74Cr -2.48Cr -4.66Cr -320.75Cr -4.68Cr -33Cr -13Cr -163.18Cr -13Cr -12Cr -515.64Cr	-104.9Cr -3.32Cr -2.86Cr -2.71Cr -2.45Cr -4.6Cr -316.86Cr -4.62Cr -32Cr -12Cr -161.2Cr -12Cr -12Cr -509.39Cr